-
Something wrong with this record ?
Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout
V. Burkina, V. Zlabek, G. Zamaratskaia,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Cytochrome P-450 CYP1A1 antagonists & inhibitors metabolism MeSH
- Cytochrome P-450 CYP2E1 metabolism MeSH
- Cytochrome P-450 CYP3A metabolism MeSH
- Dexamethasone chemistry pharmacology MeSH
- Cytochrome P-450 CYP2E1 Inhibitors MeSH
- Cytochrome P-450 CYP3A Inhibitors MeSH
- Cytochrome P-450 Enzyme Inhibitors MeSH
- Microsomes, Liver drug effects enzymology MeSH
- Kinetics MeSH
- Clotrimazole chemistry pharmacology MeSH
- Oncorhynchus mykiss metabolism MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The effects of clotrimazole (CLO) and dexamethasone (DEX), both detected in the aquatic environment, were assessed on inhibition of cytochrome P450 (CYP450) in hepatic microsomes of rainbow trout. Activity of three CYP450 isoforms: ethoxyresorufin O-deethylase (EROD; CYP1A), 7-benzyloxy-4-trifluoromethylcoumarin O-debenzylase (BFCOD; CYP3A) and p-nitrophenol hydroxylase (PNPH; CYP2E1-like protein) was investigated in the presence of four concentrations of CLO and DEX. Clotrimazole in a concentration range of 1-100μM decreased the activity of EROD and BFCOD. The inhibition was reversible, as pre-incubation of the microsomes with CLO, before addition of the substrate, had no effect. EROD activity was non-competitively inhibited with a Ki of 0.5μM, and BFCOD activity revealed competitive inhibition with a Ki of 0.04μM. The relatively low Ki for CLO inhibition of EROD and BFCOD activity may indicate that the ability of CYP1A and CYP3A to metabolize xenobiotics is reduced in the presence of CLO. PNPH activity was not affected by CLO. DEX showed no inhibitory potency on any investigated reaction. CLO, but not DEX, inhibited EROD and BFCOD activity by different mechanisms.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051172
- 003
- CZ-PrNML
- 005
- 20140410095727.0
- 007
- ta
- 008
- 140401s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.chemosphere.2013.01.050 $2 doi
- 035 __
- $a (PubMed)23466084
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Burkina, Viktoriia
- 245 10
- $a Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout / $c V. Burkina, V. Zlabek, G. Zamaratskaia,
- 520 9_
- $a The effects of clotrimazole (CLO) and dexamethasone (DEX), both detected in the aquatic environment, were assessed on inhibition of cytochrome P450 (CYP450) in hepatic microsomes of rainbow trout. Activity of three CYP450 isoforms: ethoxyresorufin O-deethylase (EROD; CYP1A), 7-benzyloxy-4-trifluoromethylcoumarin O-debenzylase (BFCOD; CYP3A) and p-nitrophenol hydroxylase (PNPH; CYP2E1-like protein) was investigated in the presence of four concentrations of CLO and DEX. Clotrimazole in a concentration range of 1-100μM decreased the activity of EROD and BFCOD. The inhibition was reversible, as pre-incubation of the microsomes with CLO, before addition of the substrate, had no effect. EROD activity was non-competitively inhibited with a Ki of 0.5μM, and BFCOD activity revealed competitive inhibition with a Ki of 0.04μM. The relatively low Ki for CLO inhibition of EROD and BFCOD activity may indicate that the ability of CYP1A and CYP3A to metabolize xenobiotics is reduced in the presence of CLO. PNPH activity was not affected by CLO. DEX showed no inhibitory potency on any investigated reaction. CLO, but not DEX, inhibited EROD and BFCOD activity by different mechanisms.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a klotrimazol $x chemie $x farmakologie $7 D003022
- 650 _2
- $a cytochrom P-450 CYP1A1 $x antagonisté a inhibitory $x metabolismus $7 D019363
- 650 _2
- $a cytochrom P-450 CYP2E1 $x metabolismus $7 D019392
- 650 _2
- $a cytochrom P-450 CYP3A $x metabolismus $7 D051544
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a dexamethason $x chemie $x farmakologie $7 D003907
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x účinky léků $x enzymologie $7 D008862
- 650 _2
- $a Oncorhynchus mykiss $x metabolismus $7 D017686
- 650 _2
- $a inhibitory cytochromu P450 CYP2E1 $7 D065691
- 650 _2
- $a inhibitory cytochromu P450 CYP3A $7 D065692
- 650 _2
- $a inhibitory cytochromu P450 $7 D065607
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zlabek, Vladimir $u -
- 700 1_
- $a Zamaratskaia, Galia $u -
- 773 0_
- $w MED00002124 $t Chemosphere $x 1879-1298 $g Roč. 92, č. 9 (2013), s. 1099-104
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23466084 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140410095817 $b ABA008
- 999 __
- $a ok $b bmc $g 1018308 $s 849752
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 92 $c 9 $d 1099-104 $i 1879-1298 $m Chemosphere $n Chemosphere $x MED00002124
- LZP __
- $a Pubmed-20140401